Research ArticleClinical Studies
Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer
STEFAN JANSSEN, BIRGITT VAN OORSCHOT, LUKAS KÄSMANN, STEVEN E. SCHILD and DIRK RADES
Anticancer Research May 2017, 37 (5) 2537-2540;
STEFAN JANSSEN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
BIRGITT VAN OORSCHOT
2Department of Radiation Oncology, University of Würzburg, Würzburg, Germany
LUKAS KÄSMANN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
STEVEN E. SCHILD
3Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
In this issue
Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer
STEFAN JANSSEN, BIRGITT VAN OORSCHOT, LUKAS KÄSMANN, STEVEN E. SCHILD, DIRK RADES
Anticancer Research May 2017, 37 (5) 2537-2540;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment
- Patient-reported Symptom Burden, Rate of Completion of Palliative Radiotherapy and 30-day Mortality in Two Groups of Cancer Patients Managed With or Without Additional Care by a Multidisciplinary Palliative Care Team
- Does Patient-reported Dyspnea Reflect Thoracic Disease Characteristics in Patients with Incurable Cancer?